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Simple ideas, endowed from the mathematical theory of control, are used in order to analyze
in general grounds the human immune system. The general principles are minimization of the
pathogen load and economy of resources. They should constrain the parameters describing the
immune system. In the simplest linear model, for example, where the response is proportional
to the load, the annihilation rate of pathogens in any tissue should be greater than the pathogen’s
average rate of growth. When nonlinearities are added, a reference value for the number of pathogens
is set, and a stability condition emerges, which relates strength of regular threats, barrier height and
annihilation rate. The stability condition allows a qualitative comparison between tissues. On the
other hand, in cancer immunity, the linear model leads to an expression for the lifetime risk, which
accounts for both the effects of carcinogens (endogenous or external) and the immune response.
PACS numbers: 87.10.Ed, 87.19.lr, 87.19.xb, 87.19.xj
Immunity and control. Human immunity is, as
there are practically all physical aspects of life, a con-
trol process. Our body senses the number of pathogens
in a tissue and a response is generated, which reduces the
pathogen load.
The system compresses a variety of sensors, signals and
effectors at the cellular level [1]. In the present paper, I
would like to present a different perspective, endowed
from the mathematical theory of control [2]. The view
allows us to stress some general trends and qualitatively
compare the response in different tissues.
The general principles are very simple: first, the
pathogen load should be minimized, and second, the used
resources should be minimal. These principles should
constrain the parameters describing the immune system
in any tissue.
Linear model. Let us consider, for example, a very
small intensity threat to a given tissue in an adult in-
dividual. The resident cells of the immune system will
trigger a response to clear the infection. These are, basi-
cally, resident cells of the innate system [3]. The simplest
available model for the response is a linear one:
dP
dτ
= αtft + aP − btP, (1)
in which the response is proportional to the threat. τ is
time, P is the number of pathogens (in some units), and
a its rate of growth, typically ∼ 1/hour for bacteria [4]. A
freely evolving group of a few streptococci, for example,
would lead in around 40 hours to a colony greater than
the number of cells in the lungs.
The coefficient bt, on the other hand, is the tissue anni-
hilation rate of pathogens which, for consistency, should
be greater than a in order that small threats do not trans-
form into acute health problems in short terms. This con-
dition requires enough number of resident immune cells
in the tissue.
Finally, αtft is the rate of entrance of pathogens into
the tissue. The constant αt < 1 will model barrier or
mucosal immunity, that is, the flow of pathogens, ft, is
partially trapped and cleared by the barrier or mucosa
(or both).
According to Eq. (1), a finite load of pathogens is al-
ways annihilated, irrespective of the total number. This
unrealistic situation is corrected in nonlinear models,
characteristic of self-regulated systems.
Nonlinear model. Ref. 5 uses different models in
order to describe the time evolution of infections in pa-
tients. We shall use a modification of their Model 5 in
order to take account of nonlinearities:
dP
dτ
= αtft + aP
(
1− P
Ps
)
− btP
1 + c∞P
. (2)
The a parameter equals 0.6 hours−1. The added nonlin-
earity limits the increase of P to values below Ps = 20,
a conventional parameter indicating sepsis. Authors of
paper [5] use an average value of b for the body of 1.5
hours−1, a value satisfying the requirement b > a, men-
tioned in the previous paragraph. The parameter c∞ = 5
limits also the immune response for high values of P .
The main deficiency of Eq. (2) is the lack of a term
modeling recruitment of other immune cells. However,
even from this simple model, we can get important prop-
erties with the help of the qualitative theory of differen-
tial equations [6].
Reference value for the number of pathogens.
I draw in Fig. 1 the r.h.s. of Eq. (2) for ft = 0 and
bt=1.5 hours
−1, which shows two of the fixed points of
the equation: P = 0 (healthy tissue), and P = Pc, which
is an unstable fixed point dividing healthy from septic
conditions. If, in the time evolution according to Eq. (2),
P reaches values greater than Pc, then the final outcome
will be a state with P close to Ps. This is the third fixed
point of the equation, not seen in the figure.
We can roughly estimate Pc by expanding the r.h.s.
of Eq. (2) in series of P , retaining linear and quadratic
terms, and equating the result to zero, we get:
Pc =
bt − a
btc∞ − a/Ps ≈
1
c∞
. (3)
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2FIG. 1. The r.h.s. of Eq. (2) for ft = 0 and bt=1.5 hours
−1. A
stable fixed point at P = 0, and an unstable one at P = Pc ≈
0.3 are signaled. A third, stable one, at P ≈ Ps, corresponds
to a septic state, which is not seen in the figure. The value of
the function at the minimum, −Vm, is indicated.
The last expression comes from neglecting a. I will as-
sume that there is a unique c∞ for all of the tissues. This
sets a reference value for Pc in the whole body. Pc
could, probably, be associated to the threshold value for
initiating recruitment of additional immune cells.
Stability condition in tissues. The response coef-
ficient bt, apart from being greater than a, depends on
the pathogen load the tissue is regularly exposed to. If
the flow of pathogens, f , is practically constant in cer-
tain time intervals, one can get an stability condition by
requiring the r.h.s. of Eq. (2) to be lower than zero. This
leads to:
αtft < Vm ≈ bt
4c∞
≈ btPc
4
. (4)
Vm is the value at the minimum defined in Fig 1. If
the inequality is violated, the r.h.s. of Eq. (2) is always
greater than zero and P increases towards Ps. The esti-
mation for Vm comes from expanding the r.h.s. in series,
in the same way as I did for Pc.
Coefficients αt and bt shall combine in each tissue in
order to guarantee Eq. (4) to hold, i.e. guarantee immu-
nity against regular threats. Higher threats would require
higher barriers (smaller αt) and higher annihilation rates
(bt). This is typical of epithelial tissues. In other cases,
for example germinal cells in testis, in order to prevent
autoimmunity the coefficient bt is reduced, which is com-
pensated by high barriers. In summary, minimization of
P leads to the condition (4) for the coefficients αt and
bt in terms of the regular pathogen flow in the tissue, ft.
Economy of resources implies that the inequality should
be near optimal.
A second consequence of the unstable fixed
point. The unstable fixed point not only sets a unique
reference value, Pc, but is also the reason for an in-
teresting property of the small-P response. When the
FIG. 2. Time evolution of P according to Eq. (2) in the
unstable regime αf = 0.05 hours−1 > Vm ≈ 0.04 hours−1.
pathogen load overcomes the stability threshold given by
Eq. (4), the fixed point slows down the increase of P .
The reason is very simple: P should traverse the region
near Pc, where the r.h.s. of Eq. (2) is near zero, that is,
where the annihilation rate of pathogens is close to its
rate of growth. This is shown in Fig. 2, where Vm ≈ 0.04
hours−1 and αf = 0.05 hours−1. The increase of P is
delayed for more than 20 hours, in spite of the fact that
the characteristic time scale of the problem is around one
hour. This delay allows recruitment of immune cells from
blood circulation.
A qualitative comparison. The following example
is a qualitative comparison between two nearby tissues:
the small and large intestines. An understanding of the
reinforced immunity of the small intestine comes from
this analysis.
I show in Fig. 3 a schematics of the density of mi-
crobes in the contact region. These microbes are mainly
commensal bacteria, but it is reasonable to assume that
the pathogen loads are proportional to these numbers.
l is a coordinate along the gut. The small bowel is
located at l < 0, and the large intestine at l > 0. The
mean value of microbes/gm experiences a jump from 104
to 1011 as we cross from the ileum to the cecum [7]. Of
course, we expect the dependence to be continuous, as
schematically represented in Fig. 3.
The parameter values for the large intestine, αl and
bl, are roughly constant. In the small intestine, however,
the parameters shall exhibit a spatial variation. αs shall
decrease and bs increase as l moves towards the distal end
of the ileum. Significant variations of the parameters
are expected due to the augmented flow of pathogens
in many orders of magnitude. This is consistent with
the distribution of Paneth cells [8], Peyer’s patches [9]
and other structures along the small bowel. Above, the
immune protection in the small intestine was said to be
“reinforced” in the sense that the coefficients αs and bs
shall vary in order to increase protection as ft increases.
3FIG. 3. Schematic representation of the density of microbes
in the gut.
Other tissues. The stability condition, Eq. (4),
allows also the analysis of tissues in which the flow of
pathogens is normal, but bt is decreased at the expenses
of lowering αt. These are, for example, the brain [10]
and testis [11], where a limit to the cellular immune re-
sponse is needed for a proper functioning of the tissue.
Recall that the values for bt can never be lower than a,
as mentioned.
In addition, there are also tissues, like the gallblad-
der, where the microbicide character of bile [12] could be
translated into a lower than average αt and, possibly, a
low bt. Notice that we have generalized the meaning of
the “barrier” coefficient, αt, not limited now to anatom-
ical or mucosal barriers.
In conclusion, I assume that the coefficients αt and
bt take different values for different tissues. The regular
flow the tissue is exposed to, ft, basically determines the
ratio bt/αt, according to Eq. (4). The tissue’s function-
ing conditions could dictate additional restrictions. For
example, in the brain bt should be relatively low, thus αt
should be decreased.
Immunity to cancer. Although the detailed dynam-
ics of cancer onset and development is very complex [13],
and partially unknown, one may guess that there should
be an inverse correlation between the annihilation rate of
pathogens in a tissue, bt, and the risk of cancer. Indeed,
the cellular immune response is not only responsible of
eliminating virus infected cells, for example, but also dys-
functional and precancerous cells in the tissue. Thus, a
low bt could be related to a higher than normal cancer
risk in that tissue. Conversely, one may obtain informa-
tion for bt from the frequency distribution of cancer in
the body tissues.
It is reasonable to assume that, for the initial stages of
tumors in a tissue, an equation similar to Eq. (1) holds:
dN
dτ
= gc + acN − bcN, (5)
where N is the (small) number of precancerous cells,
gc is the rate of creation of such cells in the tissue, ac
is their division rate, and bc - the tissue’s annihilation
rate of dysfunctional cells. ac can be estimated from the
division rate of stem cells in that tissue, ut, assuming
that cancer cells originate from stem cells [14]. Typi-
cally, ac ∼ 1/week or even smaller [15]. On the other
hand, bc ∼ bt, as noticed. Thus, bc >> ac.
For gc, we may use an equation like gc ∼ pNscut, where
Nsc is the number of stem cells, and p - a probability pa-
rameter modeling the carcinogenic effect of both internal
processes (free radicals, for example) or external factors
(double strand breaks by ionizing radiation, for example).
Equating to zero the r.h.s. of Eq. (5), we obtain the
average number of precancerous cells in the tissue:
Nc ≈ gc/bc = (put/bc)Nsc. (6)
In order to become a true tumor, these cells should pass
through a few stages [13], and avoid the adaptive immune
system. Nevertheless, it is reasonable to assume that the
lifetime risk for cancer in the tissue is proportional to Nc.
Fig 4 is a re-plot of the results by Tomasetti and Vo-
gelstein [15] (see also [16]) showing the dependence of
the lifetime risk for cancer in a tissue on the number
of stem cells, and the rate of mitotic divisions. The y-
axis in the figure is the normalized risk, i.e. the risk
per stem cell. This normalization allows comparison be-
tween tissues with high differences in the number of stem
cells. The x-axis, on the other hand, counts the num-
ber of stem cell generations along lifetime, Ngen, a num-
ber roughly proportional to the division rate, Ngen ≈
ut 80 years + log2Nsc. The last term accounts for divi-
sions along the clonal expansion phase during tissue for-
mation. The figure shows that, for a single-cell lineage,
the larger Ngen the higher the normalized risk also.
In Fig. 4, a set of 11 cancers shows a near perfect linear
correlation: risk/Nsc ∼ Ngen, where the proportionality
coefficient may be roughly written as qp/bt/80 years, and
q measures the success rate of precancerous cells: one in
ten thousand cells becomes a tumor, for example.
We shall qualify these tissues as “normal”. For all of
them, we expect very similar p and bt, although they may
exhibit very different barriers (αt). Indeed, we expect a
very low αt in the colon and skin, but αt ≈ 1 in blood,
for example. The only “special” case in this group is the
cerebellum, with a high barrier and a normal (instead
of a low) bt. This means a possibility higher than the
cerebrum to clear any infection [17].
External and genetic factors rise the risk (through p)
many times, as compared to normal tissues. For example,
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FIG. 4. Lifetime cancer risk in tissues. The figure is a re-plot of the data contained in Tomasetti and Vogelstein paper [15].
See explanation in the main text.
smoking multiplies the risk for lung cancer by roughly 20
and, in familial adenomatous polyposis patients, the risk
for colon cancer is increased by a factor around 100.
There are also tissues like the brain, germ cells, gall-
bladder, bones and the thyroid where, in addition to
genetic or external factors, the relatively high normal-
ized values for the risk lead one suspect unusually low
values of bt. The brain, germ cells and the gallbladder
were briefly discussed above. With regard to bones, it
is known that immunity relies strongly on defensins [18],
possibly with a relatively low number of resident cells.
On the other hand, the thyroid is known to have a close
cross-talk with the immune system [19]. It’s dysregula-
tion is the cause of immune disorders. One may speculate
that a low number of resident cells is needed in order to
prevent autoimmunity in the thyroid.
Finally, we have the small intestine with a normalized
risk lower than normal, possibly related to a high aver-
aged bt, a fact consistent with what was discussed above.
The results for the estimated coefficients are summa-
rized in Table I. Although they are only qualitative re-
sults, they allow comparison between tissues, and are a
first step towards the understanding of Fig. 4 for the
lifetime risks of cancer in different tissues.
Concluding remarks. In the paper, I show that sim-
ple ideas, coming from control theory, lead to interesting
results when applied to the human immune system.
In the first step, the linear model described by Eq.
(1), it is shown that stability of a tissue against small
pathogen threats requires bt > a. If this condition is not
fulfilled, a small threat would, in a few hours, become a
serious health problem.
The linear model is modified, Eq. (2), in order to con-
sider that neither the number of pathogens nor the re-
sponse can grow without limits. Healthy (P = 0) and
septic (P = Ps) states appear as fixed points of the non-
linear (self-regulated) equation. In the middle of the way,
an additional unstable fixed point, P = Pc, signals the
transition from healthy to septic regimes. I postulate
that Pc is common to all tissues. At this step, the stabil-
5Tissue Regular pathogen flow (ft) Barrier height (1/αt) Annihilation rate (bt)
Small intestine Very High High High
Colon Very High Very High Normal
Lung Very High Very High Normal
Skin Very High Very High Normal
Duodenum High High Normal
Blood Normal Normal Normal
Pancreas Normal Normal Normal
Liver High High Normal
Cerebellum Normal High Normal
Germ cells Normal High Low
Brain Normal High Low
Gallbladder Normal High Low
Bone Normal High Low
Thyroid Normal High Low
Esophagus High High Normal
Head and Neck Normal Normal Normal
TABLE I. Immunity in tissues: qualitative comparison.
ity condition is formulated as, Eq. (4):
αtft < btPc/4.
this inequality relates the regular flow of pathogens in
the tissue, ft, with the coefficients αt and bt. We may
have, for example, a very high ft along with a very small
αt and a normal bt, as in the colon. Or a normal ft, a
small αt and a small bt, as in the brain.
I notice that the distribution frequency of cancer in tis-
sues provides indications about the strength of bt. This
statement follows from an estimation of the stationary
number of precancerous cells in the tissue, which in-
volves both the probabilities of carcinogenic factors and
the strength of the immune response. A low bt, as it is
presumably the situation in the gallbladder, for example,
would mean a higher than average number of precancer-
ous cells in the tissue. These cells shall evolve and suc-
ceed in avoiding the adaptive system in order to give rise
to a cancer.
I hope that the model’s simplicity and the qualitative
results following from it will motivate immunologists to
quantify in more precise terms the immune response in
tissues and in the whole body.
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